Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Therapeutic Drug Monitoring|January 1, 1988
Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepineE Spina, T Tomson, J O Svensson, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 19, 2020
Progressive thrombosis of cervical and intracranial arteries related to Ponatinib treatment for Chronic Myeloid LeukemiaE Spina, R Renna, L A Lanterna, et al.Therapeutic Drug Monitoring|January 22, 2002
No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolitesE Spina, A Avenoso, M G Scordo, et al.Therapeutic Drug Monitoring|June 1, 1992
Interaction between fluvoxamine and imipramine/desipramine in four patientsE Spina, G M Campo, A Avenoso, et al.Annales De Genetique|January 1, 1993
Evidence of chromosomal fragile sites in schizophrenic patientsG Garofalo, R M Ragusa, A Argiolas, et al.Italian Journal of Neurological Sciences|June 1, 1983
Intra-daily oscillations in dipropylacetic acid plasma levels with two or three daily doses of dipropylacetamide in epileptic patientsF Pisani, E Spina, C Trunfio, et al.International Journal of Clinical Pharmacology Research|January 1, 1993
Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patientsE Spina, A M Pollicino, A Avenoso, et al.Therapeutic Drug Monitoring|November 14, 1997
Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsyE Spina, D Arena, M G Scordo, et al.Therapeutic Drug Monitoring|May 22, 2001
Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetineE Spina, A Avenoso, G Facciolà, et al.Therapeutic Drug Monitoring|June 1, 1993
Carbamazepine coadministration with fluoxetine or fluvoxamineE Spina, A Avenoso, A M Pollicino, et al.Pageof 10